Endpoints Slack interview: Arc Institute’s Patrick Hsu on AI bio, investingnews2025-04-30T15:05:26+00:00April 30th, 2025|Endpoints News|
Exclusive: Axiom raises $15M to build AI models for drug toxicitynews2025-04-28T11:00:01+00:00April 28th, 2025|Endpoints News|
BigHat inks Eli Lilly deal for AI antibody research, extends Series Bnews2025-04-17T11:00:01+00:00April 17th, 2025|Endpoints News|
Charm Therapeutics founder Laksh Aithani is out as CEOnews2025-04-16T21:20:24+00:00April 16th, 2025|Endpoints News|
Study: Therapy AI chatbot shows promising resultsnews2025-04-10T12:00:42+00:00April 10th, 2025|Endpoints News|
Exclusive: Former Pfizer CSO Mikael Dolsten to advise AI unicorn Formation Bionews2025-04-02T12:00:46+00:00April 2nd, 2025|Endpoints News|
Q&A: Isomorphic Labs CEO Demis Hassabis on $600M raise, AI biotech’s futurenews2025-04-01T14:34:50+00:00April 1st, 2025|Endpoints News|
Talkspace makes AI therapy podcasts for patientsnews2025-04-01T12:00:19+00:00April 1st, 2025|Endpoints News|
Isomorphic Labs gets $600M from Thrive, GV and Alphabetnews2025-03-31T11:34:13+00:00March 31st, 2025|Endpoints News|
AI scribes reduce burnout, but financial returns unclear — reportnews2025-03-27T12:00:42+00:00March 27th, 2025|Endpoints News|
